DESs (drug-eluting) in Spain: 60% by end 2005:
This article was originally published in Clinica
By the end of 2005, around 60% of all coronary artery stents implanted in Spain will be drug-eluting (DESs) - up from a current estimated 35-40%. This is according to a study by Dr Eulogio Garcia, head of the department of haemodynamics at Madrid's Gregorio Maranon hospital. The study also found that around 35% of all Spanish implantees of bare metal stents (not drug-eluting) require surgery due to restenosis within six months of the initial operation, reports El Pais.